Cancer Registry Software Market Report and Forecast 2025-2034
Description
The global cancer registry software market size was valued at USD 72.30 Million in 2024 , driven by the rising incidence of cancer and the prevalence of EHR (electronic health record). across the globe. The market is expected to grow at a CAGR of 10.40% during the forecast period of 2025-2034, with the values likely to rise from to USD 194.46 Million by 2034 .
Cancer Registry Software: Introduction
A cancer registry is an information system crafted to streamline the collection, processing, and management process of cancer-related data in patients. It plays a vital role in data surveillance as it helps identify the key areas for intervention to prevent the increasing incidence of cancer.
Cancer registry software can help in treatment development for cancer. It can be a pivotal tool to identify potential risk factors of cancer like excessive sun or chemical exposure. The collected data can be further used for identifying locations where proper care and awareness are needed.
Global Cancer Registry Software Market Analysis
With the incidence of cancer cases and digitization trends, medical practitioners have started inclining towards software and digital platforms to streamline and organize vast amounts of data efficiently, contributing to improved patient outcomes Hence, the cancer registry software market demand has increased in the historic period.
Registry Plus, developed by the Centers and Disease Control and Prevention, is an array of publicly available free software programs compliant with national standards. These programs implement the National Program of Cancer Registries (NPCR), established by Public Law 102-515. It has become a common platform among several cancer registries.
The cancer registry software market value is also expected to grow with the onset of software enabled with improved security features. For example, the latest iteration of Abstract Plus (version 6.0) includes security features like user roles, challenge questions and passwords. Additionally, all records are securely stored in Microsoft® Access, with an extra layer of protection through password encryption on all tables.
As this software offers a high degree of flexibility, it can also be customized by hospitals, clinics, laboratories, and other cancer data sources. This adaptability indicates a promising trajectory for the global market of cancer registry software in the forecast period.
Global Cancer Registry Software Market Segmentation
Cancer Registry Software Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Software Type
As per the American Cancer Society Journal, in 2023 around 1,958,310 new cancer cases and 609,820 cancer deaths are estimated to occur in the United States only. Consequently, the United States is expected to dominate the cancer registry software market share. With the authorities getting more alert and proficient in spreading relevant information through awareness campaigns, the market size is anticipated to increase. In addition, the presence of a digital equipped infrastructure is also attributed to driving the market.
The Asia Pacific is expected to lead the market, as the governments are getting informed and committed to constructing infrastructures aligned with technological advancements. The ongoing digitalization efforts across countries and a rising prevalence of telemedicine contribute to a significant surge in digital platforms and services. For instance, in India, the National Cancer Grid has installed the Koita Centre for Digital Oncology (KCDO). This centre promotes the application of digital technologies and tools to improve cancer care across the country. Such initiatives indicate that the cancer registry software market growth is certain in the future.
Global Cancer Registry Software Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Cancer Registry Software: Introduction
A cancer registry is an information system crafted to streamline the collection, processing, and management process of cancer-related data in patients. It plays a vital role in data surveillance as it helps identify the key areas for intervention to prevent the increasing incidence of cancer.
Cancer registry software can help in treatment development for cancer. It can be a pivotal tool to identify potential risk factors of cancer like excessive sun or chemical exposure. The collected data can be further used for identifying locations where proper care and awareness are needed.
Global Cancer Registry Software Market Analysis
With the incidence of cancer cases and digitization trends, medical practitioners have started inclining towards software and digital platforms to streamline and organize vast amounts of data efficiently, contributing to improved patient outcomes Hence, the cancer registry software market demand has increased in the historic period.
Registry Plus, developed by the Centers and Disease Control and Prevention, is an array of publicly available free software programs compliant with national standards. These programs implement the National Program of Cancer Registries (NPCR), established by Public Law 102-515. It has become a common platform among several cancer registries.
The cancer registry software market value is also expected to grow with the onset of software enabled with improved security features. For example, the latest iteration of Abstract Plus (version 6.0) includes security features like user roles, challenge questions and passwords. Additionally, all records are securely stored in Microsoft® Access, with an extra layer of protection through password encryption on all tables.
As this software offers a high degree of flexibility, it can also be customized by hospitals, clinics, laboratories, and other cancer data sources. This adaptability indicates a promising trajectory for the global market of cancer registry software in the forecast period.
Global Cancer Registry Software Market Segmentation
Cancer Registry Software Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Software Type
- Standalone
- Integrated
- Public Data
- Commercial Data
- Cloud-based
- On-Premises
- Cancer Reporting
- Patient Care
- Medical Research
- Government Organization
- Hospital and Medical Practices
- Research Centres and Private Payers
- Pharmaceutical, Biotechnology and Medical Device Companies
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
As per the American Cancer Society Journal, in 2023 around 1,958,310 new cancer cases and 609,820 cancer deaths are estimated to occur in the United States only. Consequently, the United States is expected to dominate the cancer registry software market share. With the authorities getting more alert and proficient in spreading relevant information through awareness campaigns, the market size is anticipated to increase. In addition, the presence of a digital equipped infrastructure is also attributed to driving the market.
The Asia Pacific is expected to lead the market, as the governments are getting informed and committed to constructing infrastructures aligned with technological advancements. The ongoing digitalization efforts across countries and a rising prevalence of telemedicine contribute to a significant surge in digital platforms and services. For instance, in India, the National Cancer Grid has installed the Koita Centre for Digital Oncology (KCDO). This centre promotes the application of digital technologies and tools to improve cancer care across the country. Such initiatives indicate that the cancer registry software market growth is certain in the future.
Global Cancer Registry Software Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Centers for Disease Control and Prevention
- IBM Corporation
- Onco, Inc
- Elekta AB (pub)
- C/NET Solution
- Ordinal Data, Inc
- Conduent, Inc
- himagine solutions
- McKesson Corporation
- IACR Official Website
- F. Hoffmann-La Roche Ltd
- NeuralFrame, Inc
- IARC
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Cancer Registry Software Market Overview
- 3.1 Global Cancer Registry Software Market Historical Value (2018-2024)
- 3.2 Global Cancer Registry Software Market Forecast Value (2025-2034)
- 4 Global Cancer Registry Software Market Landscape
- 4.1 Global Cancer Registry Software Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Cancer Registry Software Product Landscape
- 4.2.1 Analysis by Software Type
- 4.2.2 Analysis by Database
- 4.2.3 Analysis by Deployment Type
- 4.2.4 Analysis by Functionality
- 5 Global Cancer Registry Software Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Cancer Registry Software Market Segmentation
- 6.1 Global Cancer Registry Software Market by Software Type
- 6.1.1 Market Overview
- 6.1.2 Standalone
- 6.1.3 Integrated
- 6.2 Global Cancer Registry Software Market by Database
- 6.2.1 Market Overview
- 6.2.2 Public Data
- 6.2.3 Commercial Data
- 6.3 Global Cancer Registry Software Market by Deployment Type
- 6.3.1 Market Overview
- 6.3.2 Cloud-based
- 6.3.3 On-Premises
- 6.4 Global Cancer Registry Software Market by Functionality
- 6.4.1 Market Overview
- 6.4.2 Cancer Reporting
- 6.4.3 Patient Care
- 6.4.4 Medical Research
- 6.5 Global Cancer Registry Software Market by End User
- 6.5.1 Market Overview
- 6.5.2 Government Organization
- 6.5.3 Hospital and Medical Practices
- 6.5.4 Research Centres and Private Payers
- 6.5.5 Pharmaceutical, Biotechnology and Medical Device Companies
- 6.5.6 Others
- 6.6 Global Cancer Registry Software Market by Region
- 6.6.1 Market Overview
- 6.6.2 North America
- 6.6.3 Europe
- 6.6.4 Asia Pacific
- 6.6.5 Latin America
- 6.6.6 Middle East and Africa
- 7 North America Cancer Registry Software Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Cancer Registry Software Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Cancer Registry Software Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Cancer Registry Software Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Cancer Registry Software Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding & Investment Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Supplier Landscape
- 16.1 Centers for Disease Control and Prevention
- 16.1.1 Financial Analysis
- 16.1.2 Product Portfolio
- 16.1.3 Demographic Reach and Achievements
- 16.1.4 Mergers and Acquisitions
- 16.1.5 Certifications
- 16.2 IBM Corporation
- 16.2.1 Financial Analysis
- 16.2.2 Product Portfolio
- 16.2.3 Demographic Reach and Achievements
- 16.2.4 Mergers and Acquisitions
- 16.2.5 Certifications
- 16.3 Onco, Inc
- 16.3.1 Financial Analysis
- 16.3.2 Product Portfolio
- 16.3.3 Demographic Reach and Achievements
- 16.3.4 Mergers and Acquisitions
- 16.3.5 Certifications
- 16.4 Elekta AB (pub)
- 16.4.1 Financial Analysis
- 16.4.2 Financial Portfolio
- 16.4.3 Demographic Reach and Achievements
- 16.4.4 Mergers and Acquisitions
- 16.4.5 Certifications
- 16.5 C/NET Solution
- 16.5.1 Financial Analysis
- 16.5.2 Product Portfolio
- 16.5.3 Demographic Reach and Achievements
- 16.5.4 Mergers and Acquisitions
- 16.5.5 Certifications
- 16.6 Ordinal Data, Inc
- 16.6.1 Financial Analysis
- 16.6.2 Product Portfolio
- 16.6.3 Demographic Reach and Achievements
- 16.6.4 Mergers and Acquisitions
- 16.6.5 Certifications
- 16.7 Conduent, Inc
- 16.7.1 Financial Analysis
- 16.7.2 Product Portfolio
- 16.7.3 Demographic Reach and Achievements
- 16.7.4 Mergers and Acquisitions
- 16.7.5 Certifications
- 16.8 himagine solutions
- 16.8.1 Financial Analysis
- 16.8.2 Product Portfolio
- 16.8.3 Demographic Reach and Achievements
- 16.8.4 Mergers and Acquisitions
- 16.8.5 Certifications
- 16.9 McKesson Corporation
- 16.9.1 Financial Analysis
- 16.9.2 Product Portfolio
- 16.9.3 Demographic Reach and Achievements
- 16.9.4 Mergers and Acquisitions
- 16.9.5 Certifications
- 16.10 IACR Official Website
- 16.10.1 Financial Analysis
- 16.10.2 Product Portfolio
- 16.10.3 Demographic Reach and Achievements
- 16.10.4 Mergers and Acquisitions
- 16.10.5 Certifications
- 16.11 F. Hoffmann-La Roche Ltd
- 16.11.1 Financial Analysis
- 16.11.2 Product Portfolio
- 16.11.3 Demographic Reach and Achievements
- 16.11.4 Mergers and Acquisitions
- 16.11.5 Certifications
- 16.12 NeuralFrame, Inc
- 16.12.1 Financial Analysis
- 16.12.2 Product Portfolio
- 16.12.3 Demographic Reach and Achievements
- 16.12.4 Mergers and Acquisitions
- 16.12.5 Certifications
- 16.13 IARC
- 16.13.1 Financial Analysis
- 16.13.2 Product Portfolio
- 16.13.3 Demographic Reach and Achievements
- 16.13.4 Mergers and Acquisitions
- 16.13.5 Certifications
- 17 Global Cancer Registry Software Market - Distribution Model (Additional Insight)
- 17.1 Overview
- 17.2 Potential Distributors
- 17.3 Key Parameters for Distribution Partner Assessment
- 18 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 19 Company Competitiveness Analysis (Additional Insight)
- 19.1 Very Small Companies
- 19.2 Small Companies
- 19.3 Mid-Sized Companies
- 19.4 Large Companies
- 19.5 Very Large Companies
- 20 Payment Methods (Additional Insight)
- 20.1 Government Funded
- 20.2 Private Insurance
- 20.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
